CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Sinovac Biotech Ltd Company Snapshot
Sinovac Biotech Ltd operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Sinovac Biotech Ltd with three other companies in this sector in China: Lionco Pharmaceutical Group Co Ltd (2016 sales of 478.59 million Chinese Renmimbi [US$74.35 million] of which 100% was Medicine), Furen Pharmaceutical Group Industry Co Ltd (495.63 million Chinese Renmimbi [US$77.00 million] of which 95% was Pharmaceutical Industry), and Honz Pharmaceutical Co Ltd (471.46 million Chinese Renmimbi [US$73.24 million] of which 100% was Medical Industry).

Sales Analysis. During the year ended December of 2016, sales at Sinovac Biotech Ltd were 481.91 million Chinese Renmimbi (US$74.86 million). This is an increase of 13.7% versus 2015, when the company's sales were 423.91 million Chinese Renmimbi. Sales of H5n1 saw an increase that was more than double the company's growth rate: sales were up 75.5% in 2016, from 24.22 million Chinese Renmimbi to 42.51 million Chinese Renmimbi. Not all segments of Sinovac Biotech Ltd experienced an increase in sales in 2016: sales of Mumps fell 65.7% to 3.17 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales). Sinovac Biotech Ltd also experienced decreases in sales in Inactivated Hepatitis Vaccines (down 55.9% to 137.03 million Chinese Renmimbi) and Influenza Vaccines (down 17.9% to 65.40 million Chinese Renmimbi) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Sinovac Biotech Ltd
  Stock Performance Chart for Sinovac Biotech Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 52.00
(Figures in Chinese Renmimbi)
1 Week 0.2%   13 Weeks -1.6%  
4 Weeks 11.9%   52 Weeks 25.4%  
 
Sinovac Biotech Ltd Key Data:
  Ticker: SVA Country: China
  Exchanges: ASE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 481,909,518
(Year Ending Jan 2017).
Employees: 724
  Currency: Chinese Renmimbi Market Cap: 2,964,782,607
  Fiscal Yr Ends: December Shares Outstanding: 57,011,761
  Share Type: Common Closely Held Shares: 19,620,615
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.